James E. Barrett
Researcher Next ID · RN-040140
Researcher · Agricultural and Biological Sciences
Innsbruck, Austria
- Works count
- 519
- Citation count
- 9,809
- H-index
- 46
- i10-index
- 166
Research interests
Publications
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
Nature Communications · 2017 · https://doi.org/10.1038/ncomms14262
eFORGE: A Tool for Identifying Cell Type-Specific Signal in Epigenomic Data
Cell Reports · 2016 · 10.1016/j.celrep.2016.10.059
MicroRNA modulation in complex regional pain syndrome
Journal of Translational Medicine · 2011 · 10.1186/1479-5876-9-195
Hippocampal Expression Analyses Reveal Selective Association of Immediate-Early, Neuroenergetic, and Myelinogenic Pathways with Cognitive Impairment in Aged Rats
Journal of Neuroscience · 2007 · 10.1523/jneurosci.4163-06.2007
Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents
Psychopharmacology · 2007 · 10.1007/s00213-007-0710-6
WAY-163909 [(7 bR,10 aR)-1,2,3,4,8,9,10,10 a-Octahydro-7 bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Preclinical Antipsychotic-Like Activity
Journal of Pharmacology and Experimental Therapeutics · 2006 · 10.1124/jpet.106.106989
Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties
Journal of Pharmacology and Experimental Therapeutics · 2005 · https://doi.org/10.1124/jpet.105.086363
Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies
Journal of Neuroscience Research · 2004 · 10.1002/jnr.10869
Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.
PubMed · 2001
5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions
Psychopharmacology · 1993 · 10.1007/bf02247357
The relationship of presenting physical complaints to depressive symptoms in primary care patients
Journal of General Internal Medicine · 1992 · 10.1007/bf02598007
Social Support and Depressive Symptoms in the Elderly
American Journal of Epidemiology · 1992 · https://doi.org/10.1093/oxfordjournals.aje.a116297
Ethanol-like discriminative stimulus effects of non- competitive n-methyl-d-aspartate antagonists
Behavioural Pharmacology · 1991 · 10.1097/00008877-199104000-00002
Psychopathology and the Brain
Medical Entomology and Zoology · 1991
The Validity of psychiatric diagnosis
Raven Press eBooks · 1989
Recognition of depression by internists in primary care
Journal of General Internal Medicine · 1989 · 10.1007/bf02596483
Alcoholism : origins and outcome
Raven Press eBooks · 1988
Behavioral and neurochemical studies on the anticonflict actions of buspirone
Drug Development Research · 1984 · 10.1002/ddr.430040110
Treatment of depression : old controversies and new approaches
Raven Press eBooks · 1983
Childhood psychopathology and development
Raven Press eBooks · 1983
Stress and mental disorder
Raven Press eBooks · 1979
Schedule-Controlled Behavior and the Effects of Drugs
· 1978 · 10.1007/978-1-4613-3967-0_1
Prevalence of Depression Over a 12-Month Period in a Nonpatient Population
Archives of General Psychiatry · 1978 · 10.1001/archpsyc.1978.01770300083009
A Measure of Interpersonal Dependency
Journal of Personality Assessment · 1977 · https://doi.org/10.1207/s15327752jpa4106_6
Effects of alcohol, chlordiazepoxide, cocaine and pentobarbital on responding maintained under fixed-interval schedules of food or shock presentation.
Journal of Pharmacology and Experimental Therapeutics · 1976 · 10.1016/s0022-3565(25)30454-4
Current projects
No projects listed.